Dare Bioscience, Inc. (NASDAQ:DARE)
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
Loses money on what it sells.
- Revenue
- $1.4M
- Net income
- -$10.6M
- Net margin
- -749.8%
Little or no net debt.
- Total debt
- $869K
- Cash
- $11.5M
- Debt / equity
- 0.37
Covers near-term obligations, without much room.
- Current assets
- $16.9M
- Current liabilities
- $13.7M
- Current ratio
- 1.23
Consumes cash and must keep raising it.
- Operating cash flow
- -$17.7M
- Free cash flow
- -$18.2M
- FCF margin
- -1288.8%
Burning cash with under a year of runway — expect a raise.
- Shares outstanding
- 17.4M
- Share growth (1y)
- 36.6%
- Cash runway
- 8 months
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
DARE Income Statement
| Fiscal Period | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 |
| Revenue | $47.63 K | $187.55 K | $152.46 K | $1.02 M | $2.26 K | -$21.17 K |
| Revenue Growth (YoY) | 2005.57 % | 985.82 % | 499.58 % | 1708.36 % | -94.57 % | -194.36 % |
| Cost of Revenue | $180.48 K | $319.89 K | $796.97 K | $295.80 K | $1.18 M | $0.00 |
| Gross Profit | -$132.85 K | -$132.34 K | -$644.51 K | $727.88 K | -$1.17 M | -$21.17 K |
| SG&A Expense | $2.64 M | $2.59 M | $2.25 M | $1.58 M | $2.50 M | $2.38 M |
| R&D Expense | $318.91 K | $241.97 K | $152.46 K | $622.04 K | $1.18 M | $1.43 M |
| Operating Expenses | $2.96 M | $2.84 M | $2.35 M | $2.20 M | $2.50 M | $3.81 M |
| Operating Income | -$3.09 M | -$2.97 M | -$3.00 M | -$1.47 M | -$3.67 M | -$3.83 M |
| Pretax Income | -$3.16 M | -$2.98 M | -$3.00 M | -$1.44 M | -$3.56 M | -$4.02 M |
| Tax Provision | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$3.16 M | -$2.98 M | -$3.00 M | -$1.44 M | -$3.56 M | -$4.02 M |
| EPS (Basic) | -$0.18 | -$0.20 | -$0.21 | -$0.10 | -$0.28 | -$0.45 |
| EPS (Diluted) | -$0.18 | -$0.20 | -$0.21 | -$0.10 | -$0.28 | -$0.45 |
| Shares Outstanding | 17.42 M | 14.89 M | 14.52 M | 14.50 M | 12.76 M | 8.87 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
